Anna Protopapas

Anna Protopapas

Presidente en NUVALENT, INC. .

Fortuna: - $ al 31/12/2025

61 años
Health Technology
Consumer Services
Process Industries

Perfil

Anna Protopapas is Chief Executive Officer & Director at Flare Therapeutics, Inc. since 2026 and Independent Chairman at Nuvalent, Inc. since 2022.
Former roles include President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014, Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017, Director at Ensemble Therapeutics Corp., Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021, Director at Mersana Therapeutics, Inc. from 2023 to 2026, Director at Bioverativ, Inc. from 2017 to 2018, Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014, and Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Princeton University, and an MBA from Stanford Graduate School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/01/2026 0 ( -.--% ) - $ 31/12/2025

Cargos activos de Anna Protopapas

EmpresasCargoInicio
NUVALENT, INC. Presidente 30/03/2022
Director Ejecutivo 30/06/2026

Antiguos cargos conocidos de Anna Protopapas.

EmpresasCargoFin
MERSANA THERAPEUTICS Director Ejecutivo 10/09/2023
DICERNA PHARMACEUTICALS, INC. Director/Miembro de la Junta 03/06/2021
BIOVERATIV INC Director/Miembro de la Junta 08/03/2018
ARIAD PHARMACEUTICALS, INC. Director/Miembro de la Junta 16/01/2017
Corporate Officer/Principal 01/10/2014
Ver el detalle de la experiencia de Anna Protopapas.

Formación de Anna Protopapas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

83

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology